|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention relates to compositions and methods for treating cancer.
|
|
gptkbp:applicationNumber
|
10/2003/123456
|
|
gptkbp:applicationPublicationNumber
|
gptkb:US_2003/0123456_A1
|
|
gptkbp:applicationType
|
utility
|
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:clinicalTrials
|
NCT01234567
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:documentType
|
patent grant
|
|
gptkbp:examiner
|
Jane_Smith
|
|
gptkbp:expirationDate
|
March 15, 2022
|
|
gptkbp:fieldOfInvention
|
pharmaceuticals
|
|
gptkbp:filingCountry
|
gptkb:US
|
|
gptkbp:filingDate
|
March 15, 2002
|
|
gptkbp:grantDate
|
September 14, 2004
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,338 C8
|
|
gptkbp:internationalClassification
|
A61K 31/00
|
|
gptkbp:inventor
|
gptkb:Alice_Johnson
gptkb:Bob_Brown
gptkb:John_Doe
|
|
gptkbp:issuedOn
|
September 14, 2004
|
|
gptkbp:language
|
English
|
|
gptkbp:legalStatus
|
enforced
|
|
gptkbp:maintenanceFee
|
paid
|
|
gptkbp:material
|
compound X
|
|
gptkbp:nonPatentCitation
|
5
|
|
gptkbp:patentCitation
|
15
|
|
gptkbp:patentClassification
|
A61K, C07D
|
|
gptkbp:patentExpiration
|
2022-03-15
|
|
gptkbp:patentFamily
|
US_6,789,338_C8,_US_7,123,456_B2
|
|
gptkbp:patentNumber
|
6,789,338
|
|
gptkbp:patentOffice
|
gptkb:USPTO
|
|
gptkbp:patentOwner
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:patentStatus
|
active
|
|
gptkbp:patentType
|
granted
|
|
gptkbp:priorityDate
|
March 15, 2001
|
|
gptkbp:relatedPatent
|
gptkb:US_6,123,456_A1
|
|
gptkbp:relatedTo
|
gptkb:US_6,123,456_A1
|
|
gptkbp:research_areas
|
oncology
|
|
gptkbp:researchField
|
cancer treatment
|
|
gptkbp:status
|
active
|
|
gptkbp:title
|
Compositions and methods for treating cancer
|